A Randomized, Placebo-Controlled Trial of BMS-275291 Given Daily for 12 Months to Women With Stage 1c-IIIA Breast Cancer Receiving Adjuvant Chemotherapy and/or Hormonal Therapy
Clinical trial NCT00036621 · TERMINATED
Trial details
- NCT number
- NCT00036621
- Sponsor
- Bristol-Myers Squibb
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Primary completion
- 2002-09-01
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.